NCT02902523View on ClinicalTrials.gov

Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions

Healthy

Interventions

DRUG

Viread® tablet 300mg

Single dose administration(PO) in the fasted state

DRUG

HUG116 tablet 245mg

Single dose administration(PO) in the fasted state

Trial Locations (1)

13486

Huons, Seongnam-si

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY

NCT02902523 - Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter